Savara Aktie

4,54 EUR -0,06 EUR -1,30 %

08:02:20

FSE

5,37 USD +0,23 USD +4,38 %

26.11.2025

BTT

Savara jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

Marktkap.904,11 Mio. EUR

Div. Rendite0,00%

WKNA2DQ2B

ISINUS8051111016

SymbolSVRA

Savara Aktien News

Sortieren:Datum Meistgelesen

07.06.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Savara Inc. - SVRA

01.06.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Savara Inc. - SVRA

23.12.24BusinesswireSavara Announces New Employment Inducement Grant

17.12.24BusinesswireSavara Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference

22.11.24BusinesswireSavara Announces New Employment Inducement Grant

13.11.24BusinesswireSavara Announces Participation in Upcoming Healthcare Conferences

12.11.24BusinesswireSavara Reports Third Quarter 2024 Financial Results and Provides Business Update

04.11.24BusinesswireSavara to Present at the Guggenheim Inaugural Healthcare Innovation Conference

22.10.24BusinesswireSavara Announces the Rare Lung Disease, Autoimmune Pulmonary Alveolar Proteinosis (aPAP), is Highlighted on a New Episode of "The Balancing Act®” Airing on Lifetime® TV

18.10.24BusinesswireSavara Announces New Employment Inducement Grant

01.10.24BusinesswireSavara Announces Patient Journey Map for People Living with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Accepted for Poster Presentation at the CHEST 2024 Annual Meeting

27.09.24BusinesswireSavara Announces New Employment Inducement Grant

27.09.24BusinesswireSavara Announces Expanded Access Program (EAP) for Molgramostim Inhalation Solution (Molgramostim) for Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

24.09.24BusinesswireSavara Appoints Braden Parker as Chief Commercial Officer, Effective Immediately

23.09.24BusinesswireSavara to Host Analyst and Investor Webinar on September 30, 2024

06.09.24BusinesswireSavara Announces New Employment Inducement Grant

03.09.24BusinesswireSavara to Present at the H.C. Wainwright 26th Annual Global Investment Conference

16.08.24BusinesswireSavara Announces New Employment Inducement Grant

12.08.24BusinesswireSavara Reports Second Quarter 2024 Financial Results and Provides Business Update

28.06.24BusinesswireSavara Announces Pricing of $100.0 Million Underwritten Offering of Common Stock

19.05.24BusinesswireSavara Presented New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024

16.05.24BusinesswireSavara Announces New Employment Inducement Grant

09.05.24BusinesswireSavara Reports First Quarter 2024 Financial Results and Provides Business Update

07.05.24BusinesswireSavara to Present at the Citizens JMP Life Sciences Conference

08.04.24BusinesswireSavara to Present New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024

22.03.24BusinesswireSavara Announces New Employment Inducement Grant

07.03.24BusinesswireSavara Reports Fourth Quarter/Year-End 2023 Financial Results and Provides Business Update

06.03.24BusinesswireSavara to Present at the Barclays 26th Annual Global Healthcare Conference

02.02.24BusinesswireSavara Announces New Employment Inducement Grant

31.01.24BusinesswireSavara to Present at Two Upcoming Healthcare Conferences

21.12.23BusinesswireSavara Introduces aPAP ClearPath™, a GM-CSF Autoantibody Blood Test to Detect Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

20.12.23BusinesswireSavara Added to the NASDAQ Biotechnology Index

15.12.23BusinesswireSavara Announces New Employment Inducement Grant

21.11.23BusinesswireSavara to Present at the Piper Sandler 35th Annual Healthcare Conference

09.11.23BusinesswireSavara Reports Third Quarter Financial Results and Provides Business Update

08.11.23BusinesswireSavara to Present at the Jefferies London Healthcare Conference

06.10.23BusinesswireSavara Announces New Employment Inducement Grant

05.09.23BusinesswireSavara to Present at the H.C. Wainwright 25th Annual Global Investment Conference

10.08.23BusinesswireSavara Reports Second Quarter Financial Results and Provides Business Update

04.08.23BusinesswireSavara Announces New Employment Inducement Grant

Savara News

Savara News: auf dieser Seite finden Sie alle Savara News und Nachrichten zur Savara Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Savara News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Savara News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.